Wanjia (HKG:0401) returned to an attributable profit of HK$1.26 billion in the half-year ended Sept. 30 from a loss of HK$3.05 billion in the year-ago period, according to a Monday filing with the Hong Kong Exchange.

The pharmaceutical distribution company posted earnings per share of HK$0.0022, compared with a loss per share of HK$0.0054 in the previous year.

Revenue in the fiscal first half fell 10% to HK$83.7 billion from HK$93.4 billion a year earlier.

Price (HKD): $0.08, Change: $+0.0070, Percent Change: +10.00%